AU1142083A - Lisergic acid derivatives - Google Patents
Lisergic acid derivativesInfo
- Publication number
- AU1142083A AU1142083A AU11420/83A AU1142083A AU1142083A AU 1142083 A AU1142083 A AU 1142083A AU 11420/83 A AU11420/83 A AU 11420/83A AU 1142083 A AU1142083 A AU 1142083A AU 1142083 A AU1142083 A AU 1142083A
- Authority
- AU
- Australia
- Prior art keywords
- acid derivatives
- lisergic
- lisergic acid
- derivatives
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH98782 | 1982-02-17 | ||
| CH987825 | 1982-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1142083A true AU1142083A (en) | 1983-08-25 |
Family
ID=4199836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11420/83A Abandoned AU1142083A (en) | 1982-02-17 | 1983-02-15 | Lisergic acid derivatives |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS58152884A (cs) |
| AU (1) | AU1142083A (cs) |
| BE (1) | BE895898A (cs) |
| CS (1) | CS236786B2 (cs) |
| DD (1) | DD209458A5 (cs) |
| DE (1) | DE3304361A1 (cs) |
| DK (1) | DK66483A (cs) |
| ES (1) | ES519811A0 (cs) |
| FI (1) | FI830462A7 (cs) |
| FR (1) | FR2521562B1 (cs) |
| GB (1) | GB2115811B (cs) |
| GR (1) | GR79562B (cs) |
| IT (1) | IT1197578B (cs) |
| NL (1) | NL8300558A (cs) |
| NO (1) | NO830482L (cs) |
| PL (1) | PL240608A1 (cs) |
| PT (1) | PT76242B (cs) |
| SE (1) | SE8300865L (cs) |
| ZA (1) | ZA831089B (cs) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU578169B2 (en) * | 1985-10-01 | 1988-10-13 | Eli Lilly And Company | N-alkylation of dihydrolysergic acid |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0808326D0 (en) * | 2008-05-08 | 2008-06-18 | E Therapeutics Plc | Compositions and methods for the treatment of fybromyalgia |
-
1983
- 1983-02-09 DE DE19833304361 patent/DE3304361A1/de not_active Withdrawn
- 1983-02-10 FI FI830462A patent/FI830462A7/fi not_active Application Discontinuation
- 1983-02-14 GB GB08304011A patent/GB2115811B/en not_active Expired
- 1983-02-14 FR FR8302463A patent/FR2521562B1/fr not_active Expired
- 1983-02-14 NO NO830482A patent/NO830482L/no unknown
- 1983-02-14 BE BE1/10724A patent/BE895898A/fr not_active IP Right Cessation
- 1983-02-15 AU AU11420/83A patent/AU1142083A/en not_active Abandoned
- 1983-02-15 ES ES519811A patent/ES519811A0/es active Granted
- 1983-02-15 NL NL8300558A patent/NL8300558A/nl not_active Application Discontinuation
- 1983-02-15 DK DK66483A patent/DK66483A/da not_active Application Discontinuation
- 1983-02-16 SE SE8300865A patent/SE8300865L/xx not_active Application Discontinuation
- 1983-02-16 PL PL24060883A patent/PL240608A1/xx unknown
- 1983-02-16 JP JP58025455A patent/JPS58152884A/ja active Pending
- 1983-02-16 GR GR70512A patent/GR79562B/el unknown
- 1983-02-16 PT PT76242A patent/PT76242B/pt unknown
- 1983-02-17 IT IT47734/83A patent/IT1197578B/it active
- 1983-02-17 ZA ZA831089A patent/ZA831089B/xx unknown
- 1983-02-17 CS CS831070A patent/CS236786B2/cs unknown
- 1983-02-17 DD DD83248035A patent/DD209458A5/de unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU578169B2 (en) * | 1985-10-01 | 1988-10-13 | Eli Lilly And Company | N-alkylation of dihydrolysergic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| ES8407060A1 (es) | 1984-08-16 |
| DE3304361A1 (de) | 1983-08-25 |
| FI830462L (fi) | 1983-08-18 |
| SE8300865D0 (sv) | 1983-02-16 |
| SE8300865L (sv) | 1983-08-18 |
| NL8300558A (nl) | 1983-09-16 |
| FI830462A0 (fi) | 1983-02-10 |
| DK66483A (da) | 1983-08-18 |
| PL240608A1 (en) | 1984-10-08 |
| GB2115811B (en) | 1985-08-14 |
| PT76242A (en) | 1983-03-01 |
| NO830482L (no) | 1983-08-18 |
| JPS58152884A (ja) | 1983-09-10 |
| FR2521562B1 (fr) | 1985-10-25 |
| GB2115811A (en) | 1983-09-14 |
| ES519811A0 (es) | 1984-08-16 |
| PT76242B (en) | 1986-01-10 |
| GR79562B (cs) | 1984-10-30 |
| GB8304011D0 (en) | 1983-03-16 |
| BE895898A (fr) | 1983-08-16 |
| CS236786B2 (en) | 1985-05-15 |
| DD209458A5 (de) | 1984-05-09 |
| FI830462A7 (fi) | 1983-08-18 |
| IT8347734A0 (it) | 1983-02-17 |
| IT1197578B (it) | 1988-12-06 |
| FR2521562A1 (fr) | 1983-08-19 |
| ZA831089B (en) | 1984-09-26 |
| DK66483D0 (da) | 1983-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1619488A (en) | Carboxyalkenoic acid derivatives | |
| AU540147B2 (en) | Cyclopentanonealkenoic acid derivatives | |
| AU1035183A (en) | Ascorbic acid derivatives | |
| AU2060283A (en) | Alpha-aryl-1h-azolyl-1-ethanol derivatives | |
| AU1425183A (en) | I-piperazine derivatives | |
| AU559513B2 (en) | Diphosphonic acid derivatives | |
| AU1400283A (en) | Benzodiazipine derivatives | |
| AU1990483A (en) | Propynylaminoisoxazole derivatives | |
| AU558627B2 (en) | 2-oxo-1-azetidinesulphonic acids derivatives | |
| AU1800483A (en) | Desoxyuridine derivatives | |
| AU1565783A (en) | Oxazoleacetic acid derivatives | |
| AU2190083A (en) | N-substituted-phenothiazine derivatives | |
| AU1962583A (en) | Thiatriazine derivatives | |
| AU563736B2 (en) | Lysergic acid derivatives | |
| AU565379B2 (en) | Carbazic acid derivatives | |
| AU1841983A (en) | Pesticidal phenylcarbamoylbarbituric acid derivatives | |
| AU1867883A (en) | Sulfamoylbenzophenone derivatives | |
| AU558459B2 (en) | Apovincaminic acid derivatives | |
| AU6817281A (en) | 2-penem-3-carboxylic acid derivatives | |
| AU1719383A (en) | Clavulanic acid derivatives | |
| AU1382583A (en) | Indolizidinylbenzamide derivatives | |
| AU6826581A (en) | Beta-aminoisothiazolylacetamido-3-cephem-4-carboxylic acid derivatives | |
| AU2148883A (en) | Acridanone derivatives | |
| AU539442B2 (en) | Indol-3-acetic acid derivatives | |
| AU1142083A (en) | Lisergic acid derivatives |